ARCHIVES

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Cancer Prevention Fellowship Program Offers Enhancement

March 8, 1991

NCI Announces Designation Of Comprehensive Center

July 20, 1990

Next issue of The Cancer Letter is scheduled for Jan. 7, 2005.

December 10, 2004

Budget Difficulties Aside, Centers Important To NCI, Broder Asserts; Warns Against Sabotage.

July 12, 1991

In Brief: Edward Sondik Named Director Of CDC’s National Center for Health Statistics

April 12, 1996

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

January 17, 1992